Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation

18 Apr 2016

Abstract excerpt

// Francesco Paolo Fiorentino 1 , Elvan Tokgün 1 , Sònia Solé-Sánchez 1 , Sabrina Giampaolo 1 , Onur Tokgün 1 , Toni Jauset 2 , Takashi Kohno 3 , Manuel Perucho 1, 4 , Laura Soucek 2, 4, 5 , Jun Yokota 1, 3 1 Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Campus Can Ruti, Barcelona, Spain 2 Vall...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27105536
DOI: 10.18632/oncotarget.8826

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivationPMID 27105536Read ↗

C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug TargetSemantic proximity Read ↗

FOXM1 targeting alters AURKB activity and reshapes antitumor immunity to curb the progression of small cell lung cancerSemantic proximity Read ↗

P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic ModulationSemantic proximity Read ↗

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancerSemantic proximity Read ↗

BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancerSemantic proximity Read ↗

Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc.Semantic proximity Read ↗

A framework for identification of actionable cancer genome dependencies in small cell lung cancerSemantic proximity Read ↗

Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancerSemantic proximity Read ↗

Family matters: How MYC family oncogenes impact small cell lung cancerSemantic proximity Read ↗

Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung CancerSemantic proximity Read ↗

Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.Semantic proximity Read ↗

NEMO- and RelA-dependent NF-κB signaling promotes small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.